Suppressing thrombin generation is compatible with the development of atherosclerosis in mice
Suppressing thrombin generation is compatible with the development of atherosclerosis in mice
Thrombin has been proposed to play a key role in the development of atherosclerosis, both by promoting fibrin deposition into the atherosclerotic vessel wall and also by signalling through thrombin receptors. Unfortunately, mice homozygous for a deletion of the prothrombin gene (FII) die in utero, making a direct assessment of the role of thrombin during atherogenesis difficult. We have assessed the contribution of thrombin-dependent processes to vascular lipid lesion formation in the atherosclerosis-prone apolipoprotein E (ApoE)-deficient mice by inhibiting thrombin generation with warfarin. ApoE?/? mice were treated with warfarin at a dose that increased the prothrombin time (PT) more than 10-fold (250–375 ?g/kg body weight/day) for 12 weeks from the age of 12 weeks onwards. The extent and composition of the vascular lipid lesions that developed were assessed using oil red O to measure neutral lipid in the vessel wall and quantitative immunofluoresence to measure fibrin(ogen) levels as well as macrophage and smooth muscle cell numbers. Mice treated with warfarin developed lesions both in the aortic sinus and the descending aorta to the same degree as mice receiving no treatment (28,351±350 ?m2/mouse treated with warfarin versus 27,952±750 ?m2/control mouse; P=.86). However, the amount of fibrin(ogen) deposited in the vessel wall was decreased by more than 60% (34±11 arbitrary units in warfarin treated mice versus 92±11 arbitrary units in control mice; P<.01). Staining of macrophage and for smooth muscle cell markers was unaltered by treatment with warfarin. We conclude that suppressing thrombin generation does not alter the development of vascular lipid lesions in mice with a severe disorder of lipid metabolism, despite a marked reduction in fibrin(ogen) deposition.
thrombosis, atherosclerosis, macrophages, anticoagulants, smooth muscle
71-80
Grainger, David J.
688ef1c3-cd36-4273-b53d-81ded5520721
McWilliam, Nicola A.
8edeef55-8ff7-4985-8032-e9582bd5fc17
Baglin, Trevor P.
5dd85c0b-9143-4558-b688-97212c2199b5
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
2001
Grainger, David J.
688ef1c3-cd36-4273-b53d-81ded5520721
McWilliam, Nicola A.
8edeef55-8ff7-4985-8032-e9582bd5fc17
Baglin, Trevor P.
5dd85c0b-9143-4558-b688-97212c2199b5
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Grainger, David J., McWilliam, Nicola A., Baglin, Trevor P. and Byrne, Christopher D.
(2001)
Suppressing thrombin generation is compatible with the development of atherosclerosis in mice.
Thrombosis Research, 102 (1), .
(doi:10.1016/S0049-3848(01)00211-0).
Abstract
Thrombin has been proposed to play a key role in the development of atherosclerosis, both by promoting fibrin deposition into the atherosclerotic vessel wall and also by signalling through thrombin receptors. Unfortunately, mice homozygous for a deletion of the prothrombin gene (FII) die in utero, making a direct assessment of the role of thrombin during atherogenesis difficult. We have assessed the contribution of thrombin-dependent processes to vascular lipid lesion formation in the atherosclerosis-prone apolipoprotein E (ApoE)-deficient mice by inhibiting thrombin generation with warfarin. ApoE?/? mice were treated with warfarin at a dose that increased the prothrombin time (PT) more than 10-fold (250–375 ?g/kg body weight/day) for 12 weeks from the age of 12 weeks onwards. The extent and composition of the vascular lipid lesions that developed were assessed using oil red O to measure neutral lipid in the vessel wall and quantitative immunofluoresence to measure fibrin(ogen) levels as well as macrophage and smooth muscle cell numbers. Mice treated with warfarin developed lesions both in the aortic sinus and the descending aorta to the same degree as mice receiving no treatment (28,351±350 ?m2/mouse treated with warfarin versus 27,952±750 ?m2/control mouse; P=.86). However, the amount of fibrin(ogen) deposited in the vessel wall was decreased by more than 60% (34±11 arbitrary units in warfarin treated mice versus 92±11 arbitrary units in control mice; P<.01). Staining of macrophage and for smooth muscle cell markers was unaltered by treatment with warfarin. We conclude that suppressing thrombin generation does not alter the development of vascular lipid lesions in mice with a severe disorder of lipid metabolism, despite a marked reduction in fibrin(ogen) deposition.
This record has no associated files available for download.
More information
Published date: 2001
Keywords:
thrombosis, atherosclerosis, macrophages, anticoagulants, smooth muscle
Identifiers
Local EPrints ID: 25554
URI: http://eprints.soton.ac.uk/id/eprint/25554
ISSN: 0049-3848
PURE UUID: f5815633-c214-4210-8794-e480b9e60384
Catalogue record
Date deposited: 07 Apr 2006
Last modified: 16 Mar 2024 03:07
Export record
Altmetrics
Contributors
Author:
David J. Grainger
Author:
Nicola A. McWilliam
Author:
Trevor P. Baglin
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics